19:38 , Dec 20, 2016 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Neurology Patient sample and mouse studies suggest miR-338-3p could help treat psychiatric symptoms in patients with 22q11.2 deletion syndrome. In a mouse model of the syndrome, injection of an adeno-associated viral (AAV) vector encoding...